GeneralBreaking NewsBreakingLatest News
Deepinder Goyal and Dr. Cyriac Abby Philips Clash Over Temple Device
Sentiment: NeutralHigh Priority
What Happened?
Zomato co-founder Deepinder Goyal and hepatologist Dr. Cyriac Abby Philips are engaged in a public dispute over Goyal's Rs 85,000 device, Temple. Goyal defends the device's credibility, while Philips questions its scientific validity.
Key points
- Deepinder Goyal claims to have invested $20 million in the development of Temple.
- The device is marketed as a fitness tracker that monitors brain blood flow.
- Dr. Philips accuses Temple of being a scam and questions its scientific claims.
- Goyal asserts that Temple is not a medical device but a wellness product.
- The public dispute escalated on social media, particularly on X.
Key insights
- The clash may impact consumer trust in emerging health technologies.
- Goyal's defense could influence perceptions of startup accountability in healthcare.
- Philips' criticisms may lead to increased scrutiny of wearable health devices.
Why it matters
The dispute highlights concerns over the scientific validity of new health technologies.
Entities
Deepinder Goyal· PersonDr. Cyriac Abby Philips· PersonTemple· ProductZomato· Company
Source
India Today
